Papers (9189)

Page 154 of 154, ranked by citation count.

• Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF. Hypertens Res · 2026 · 0 citations
• [Medication or lifestyle for obesity? New medication is a wake-up call for the general practitioner]. Ned Tijdschr Geneeskd · 2022 · 0 citations
• Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles. J Extracell Biol · 2025 · 0 citations
• Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis. Cureus · 2025 · 0 citations
• Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness. medRxiv · 2023 · 0 citations
• Digital multicriteria evaluation of negotiated medicines using Chinese mini-HTA: application of structured methodologies in assessing once-weekly GLP-1 RAs for improved clinical decision-making. Front Pharmacol · 2025 · 0 citations
• Incretin-Based Therapies and Heart Failure Outcomes: Benefit Beyond Weight Loss? J Am Coll Cardiol · 2025 · 0 citations
• Web Exclusive. Annals On Call - Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control Is Inadequate With Dulaglutide. Ann Intern Med · 2025 · 0 citations
• The role of dulaglutide in the treatment of alcohol use disorder: a case report. Front Psychiatry · 2025 · 0 citations